News
Regeneron’s Eylea franchise remains resilient despite biosimilar competition. Read what makes REGN stock a Strong Buy despite ...
Hosted on MSN29d
Why Is Regeneron (REGN) Down 4.1% Since Last Earnings Report?Praluent’s net sales in the United States ... A regulatory application for a pre-filled syringe was submitted to the FDA and a decision is expected by mid-2025. The European Commission (EC ...
Compared with a statin alone, the addition of Praluent cost $308 000 per quality-adjusted life year (QALY) gained. But the addition of ezetimibe cost $81 000 per QALY compared with a statin alone.
Additionally, Praluent was associated with a 15% lower risk of death from any cause, which occurred in 334 (3.5%) of patients in the Praluent group and 392 (4.1%) of patients in the placebo group.
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for ...
A Maui doctor tried to use two syringes on his wife after pushing her off a hiking trail and hitting her head with a rock about 10 times, police said in court documents released Thursday.
Dupixent is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available for COPD. Dupixent is intended for injection under the skin (subcutaneous injection) and ...
About Dupixent Dupixent is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available for COPD. Dupixent is intended for injection under the skin ...
Dupixent is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available for COPD. Dupixent is intended for injection under the skin (subcutaneous injection ...
Brain fog is a general level of confusion and disorientation, says Robert Rosenson, MD, director of the Cardiometabolic Unit at Mount Sinai Hospital in New York City. The FDA approved label ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results